Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Kidney Cancer
Related studies linked through entity extraction aliases.
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
- Status
- COMPLETED
- Phase
- PHASE2
Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
- Status
- UNKNOWN
- Phase
- PHASE2
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
- Status
- COMPLETED
- Phase
- N/A
Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
- Status
- COMPLETED
- Phase
- PHASE3
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
- Status
- RECRUITING
- Phase
- N/A
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
- Status
- UNKNOWN
- Phase
- PHASE3
Erlotinib in Treating Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1